Clinical Trial

Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this trial is to study if the concomitant administration of Telmisartan, Cilostazol IR (immediate release), and Metformin ER (extended release) can help stroke survivors make greater gains in movement and recovery during robot-assisted arm and hand rehabilitation.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-15
notable Primary completion pushed: 2027-10-31 -> 2027-12-31 2026-07-15
Trial Details
NCT Number NCT07588932
Lead Sponsor Spaulding Rehabilitation Hospital
Collaborators: Neuro-Innovators, Inc.
Conditions Stroke
Enrollment 50 participants
Start Date 2026-05-18
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14